Clinical Trials Directory

Trials / Completed

CompletedNCT00131287

The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
108 (planned)
Sponsor
ECbiotech Taiwan · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine whether the extract of the Agaricus blazei Murill mushroom is effective in the supplementary treatment of type II DM patients.

Detailed description

The researchers have the animal model that the extract of the Agaricus blazei Murill mushroom is effective in the treatment of type II DM mice conducted on 2002. The dose effects were also found. The researchers conducted the pilot study also showing the same effects in 2003. So the researchers designed this trial. The elixir of the Agaricus blazei Murill mushroom is popular in Taiwan for chronic diseases, such as type II DM.

Conditions

Interventions

TypeNameDescription
DRUGExtract of Agaricus blazei Murill

Timeline

Start date
2005-07-01
Completion
2006-12-01
First posted
2005-08-18
Last updated
2010-01-05

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT00131287. Inclusion in this directory is not an endorsement.